Who is sponsoring NCT03189823?

NCT03189823 is sponsored by Radboud University Medical Center.

What drugs are being tested in NCT03189823?

Interventions in NCT03189823: Specify, model 3998, Medtronic Inc., Minneapolis, MN, USA.

What condition does NCT03189823 study?

NCT03189823 studies Pain, Intractable, Central Pain Syndrome, Facial Pain.

Is NCT03189823 still recruiting?

NCT03189823 is currently completed. Last updated 16 June 2017.

Last reviewed 2017-06-16 · How we verify

NCT03189823: MCSNL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Long-term Effect of Motor Cortex Stimulation in Patients Suffering From Chronic Neuropathic Pain

Completed Last updated 16 June 2017

What this trial tests

trial testing Specify, model 3998, Medtronic Inc., Minneapolis, MN, USA in Pain, Intractable in 17 participants. Completed in 31 December 2016.

Timeline

1 January 2003

Primary endpoint
31 December 2016

31 December 2016

Quick facts

Lead sponsor	Radboud University Medical Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	17
Start date	1 January 2003
Primary completion	31 December 2016
Estimated completion	31 December 2016

Drugs / interventions tested

Specify, model 3998, Medtronic Inc., Minneapolis, MN, USA

Conditions studied

Pain, Intractable — all drugs for Pain, Intractable →
Central Pain Syndrome — all drugs for Central Pain Syndrome →
Facial Pain — all drugs for Facial Pain →

Sponsor

Radboud University Medical Center

Who can join

Adults 18 to 80, any sex, with Pain, Intractable or Central Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In order to create insights in the effects of Motor cortex stimulation (MCS) on intractable pain, an open observational study was started in 2003. The aim of this research is to: 1. to determine the clinical effectivity of MCS on pain intensity after 1 month, 1 year and 3 years of stimulation 2. to determine the clinical effectivity of MCS on QoL and daity medication intake after 3 years of MCS

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Long-term effect of motor cortex stimulation in patients suffering from chronic neuropathic pain: An observational study.
Henssen DJHA, Kurt E, van Cappellen van Walsum AM, Arnts I, et al · · 2018 · cited 20× · PMID 29381725 · DOI 10.1371/journal.pone.0191774

Verify or expand the search:

Other recruiting trials for Pain, Intractable

Currently open trials in the same condition.

NCT07095036 — Sensory Spinal Cord Stimulation · NA · recruiting
NCT06596681 — A Study of the Safety and Tolerability of GA in the Treatment of Patients With Refractory Neuropathic Pain · EARLY_PHASE1 · recruiting
NCT05398003 — Medullary Stimulation for the Treatment of Refractory Neck Pain (S2M) · NA · recruiting
NCT05761392 — APP-based Precise Management System of Chronic Intractable Pain · NA · recruiting
NCT04727216 — Intermittent vs. Continuous Dorsal Root Ganglion Stimulation · NA · active not recruiting

Other Radboud University Medical Center trials

Trials by the same sponsor.

NCT07485569 — Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · Phase 1 · not yet recruiting
NCT07514325 — MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer · NA · not yet recruiting
NCT07530263 — Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) · Phase 1 · not yet recruiting
NCT07532577 — Intranasal Insulin to Prevent Intensive Care Unit Delirium · Phase 2, PHASE3 · not yet recruiting
NCT07504172 — Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03189823 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Radboud University Medical Center
Last refreshed: 16 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03189823.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing